Investigation of carbapenemases and aminoglycoside modifying enzymes of Acinetobacter baumannii isolates recovered from patients admitted to intensive care units in a tertiary-care hospital in Brazil

被引:11
作者
Polotto, Milena [1 ,2 ]
Casella, Tiago [2 ]
Tolentino, Fernanda Modesto [1 ,2 ]
Mataruco, Mayra Mioto [3 ]
Madela Porto, Naiady Konno [2 ]
Batista Binhardi, Mirella Fontana [1 ]
Lelles Nogueira, Mara Correa [2 ]
机构
[1] Ctr Lab Reg Sao Jose do Rio Preto, Inst Adolfo Lutz, Sao Jose Do Rio Preto, SP, Brazil
[2] Fac Med Sao Jose do Rio Preto, Ctr Invest Microrganismos, Sao Jose Do Rio Preto, SP, Brazil
[3] Univ Fed Sao Carlos, Sao Carlos, SP, Brazil
关键词
Acinetobacter baumannii; Carbapenemases; Aminoglycoside modifying enzymes; TREATMENT OPTIONS; RESISTANT; IDENTIFICATION; MECHANISMS;
D O I
10.1590/0037-8682-0094-2019
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: Acinetobacter baumannii are opportunistic bacteria. highly capable of acquiring antimicrobial resistance through the production of carbapenemases and aminoglycoside modifying enzymes (AMEs). Methods: Carbapenemase and AME genes were investigated in A. baumannii recovered from inpatients of a Brazilian hospital. Results: The key genes found were bla(OXA-51-like) the association ISAba1- bla(OXA-23-like), and the AME genes aph(3')-VI, aac(6')-Ib, aac(3)-Ia, and aph(3')-Ia. Different clusters , spread through the institution wards. Conclusions: The dissemination of bla(OXA-23-like) and AME-carrying A. baumannii through the hospital highlights the need for improved preventive measures to reduce the spread of infection.
引用
收藏
页数:4
相关论文
共 15 条
[1]   Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex [J].
Akers, Kevin S. ;
Chaney, Chris ;
Barsoumian, Alice ;
Beckius, Miriam ;
Zera, Wendy ;
Yu, Xin ;
Guymon, Charles ;
Keen, Edward F., III ;
Robinson, Brian J. ;
Mende, Katrin ;
Murray, Clinton K. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) :1132-1138
[2]   Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities [J].
Asif, Muhammad ;
Alvi, Iqbal Ahmad ;
Rehman, Shafiq Ur .
INFECTION AND DRUG RESISTANCE, 2018, 11 :1249-1260
[3]   Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality [J].
Ciginskiene, Ausra ;
Dambrauskiene, Asta ;
Rello, Jordi ;
Adukauskiene, Dalia .
MEDICINA-LITHUANIA, 2019, 55 (02)
[4]   Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii [J].
Corvec, Stephane ;
Poirel, Laurent ;
Naas, Thierry ;
Drugeon, Henri ;
Nordmann, Patrice .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1530-1533
[5]   16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides [J].
Doi, Yohei ;
Arakawa, Yoshichika .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (01) :88-94
[6]   Acinetobacter baumannii An emerging opportunistic pathogen [J].
Howard, Aoife ;
O'Donoghue, Michael ;
Feeney, Audrey ;
Sleator, Roy D. .
VIRULENCE, 2012, 3 (03) :243-250
[7]   Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences [J].
Krawczyk, B ;
Lewandowski, K ;
Kur, J .
MOLECULAR AND CELLULAR PROBES, 2002, 16 (01) :1-11
[8]   A comparative study of class 1 integrons in Acinetobacter baumannii [J].
Liu, Chih-Chin ;
Tang, Chuan Yi ;
Chang, Kai-Chih ;
Kuo, Han-Yueh ;
Liou, Ming-Li .
GENE, 2014, 544 (01) :75-82
[9]   Costs of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial-Susceptible Organisms [J].
Neidell, Matthew J. ;
Cohen, Bevin ;
Furuya, Yoko ;
Hill, Jennifer ;
Jeon, Christie Y. ;
Glied, Sherry ;
Larson, Elaine L. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) :807-815
[10]   High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial [J].
Nowak, J. ;
Zander, E. ;
Stefanik, D. ;
Higgins, P. G. ;
Roca, I. ;
Vila, J. ;
McConnell, M. J. ;
Cisneros, J. M. ;
Seifert, H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (12) :3277-3282